IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
Author:
Scovell Jason M.ORCID,
Stovsky Mark,
Partin Alan,
Lotan Yair,
Baniel Jack,
Dineen Martin,
Hafron Jason,
Manickam Kannan,
Pliskin Marc,
Wagner Matthew,
Kestranek Aimee,
Klein Eric A.
Reference11 articles.
1. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening;Smith;CA Cancer J Clin,2017
2. Clinically localized prostate cancer: AUA/ASTRO Guideline, Part I: introduction, risk assessment, staging, and risk-based management;Eastham;J Urol,2022
3. American Cancer Society guideline for the early detection of prostate cancer: update 2010;Wolf;CA Cancer J Clin,2010
4. Complications after prostate biopsy: data from SEER-Medicare;Loeb;J Urol,2011
5. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schroder;Lancet,2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献